COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1977.5 | 6 | 0289-0505 | 333.16 | 504.68 | 199 | 54.87 | 0.831 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4330.7 | 6 | 0290-0509 | 934.43 | 509.12 | 471 | 88.57 | 0.755 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 758.7 | 6 | 0291-0510 | 601.38 | 510.61 | 350 | 70.43 | 0.887 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2606.5 | 6 | 0292-0512 | 911.09 | 511.98 | 298 | 68.18 | 0.805 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1530.8 | 6 | 0293-0514 | 516.97 | 514.15 | 236 | 57.70 | 0.891 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1289.3 | 6 | 0294-0515 | 42.43 | 515.91 | 283 | 62.18 | 0.920 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1372.0 | 6 | 0295-0516 | 653.99 | 516.16 | 302 | 66.18 | 0.866 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1227.0 | 6 | 0296-0518 | 896.99 | 517.89 | 228 | 60.77 | 0.776 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4036.4 | 6 | 0297-0518 | 64.81 | 518.39 | 236 | 56.77 | 0.920 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1093.1 | 6 | 0298-0521 | 259.18 | 521.20 | 288 | 64.43 | 0.872 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2260.6 | 6 | 0299-0522 | 759.26 | 522.01 | 321 | 66.77 | 0.905 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1027.9 | 6 | 0300-0521 | 695.19 | 521.83 | 316 | 67.84 | 0.863 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1114.3 | 6 | 0301-0524 | 307.39 | 524.49 | 237 | 63.60 | 0.736 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2971.1 | 6 | 0302-0524 | 537.36 | 523.04 | 202 | 57.36 | 0.772 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3229.7 | 6 | 0303-0526 | 738.26 | 525.71 | 335 | 67.11 | 0.935 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2737.9 | 6 | 0304-0530 | 442.40 | 529.89 | 215 | 53.94 | 0.929 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1617.6 | 6 | 0305-0529 | 222.70 | 529.77 | 259 | 62.77 | 0.826 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1409.1 | 6 | 0306-0533 | 148.88 | 533.45 | 266 | 64.77 | 0.797 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1953.9 | 6 | 0307-0537 | 520.57 | 536.09 | 307 | 66.18 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 835.6 | 6 | 0308-0540 | 795.24 | 540.18 | 237 | 62.77 | 0.756 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 898.1 | 6 | 0309-0541 | 927.11 | 540.64 | 263 | 61.36 | 0.878 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1672.2 | 6 | 0310-0541 | 111.28 | 540.83 | 251 | 61.94 | 0.822 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3387.3 | 6 | 0311-0538 | 356.39 | 538.08 | 144 | 45.36 | 0.880 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2178.0 | 6 | 0312-0542 | 430.57 | 542.86 | 238 | 62.43 | 0.767 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1991.4 | 6 | 0313-0544 | 37.62 | 545.15 | 245 | 60.18 | 0.850 |